Parkpine Inc – Trademark Portfolio

Entity Type: 03

Parkpine Inc holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GLOBAL VENTURES SUMMIT SILICON VALLEY TOURS THE WORLD. The owner is based in Menlo Park, CA.

405 El Camino Real - 424

Menlo Park, CA 94025

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Parkpine Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Parkpine Inc have?

Parkpine Inc has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 1 cancelled.

What trademark classes does Parkpine Inc file in?

Parkpine Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What are Parkpine Inc's most well-known trademarks?

Parkpine Inc's registered trademark portfolio includes well-known marks such as GLOBAL VENTURES SUMMIT SILICON VALLEY TOURS THE WORLD. These are among 1 currently registered trademark in the portfolio.

What is Parkpine Inc's trademark registration success rate?

Parkpine Inc has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.